Allergy Therapeutics PLC Stock
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Allergy Therapeutics PLC | -14.470% | 26.667% | 31.034% | -20.000% | 76.744% | -83.478% | - |
Alliance Pharma plc | 1.140% | -7.368% | -14.563% | -52.109% | -12.871% | -67.706% | - |
Cellectar BioSciences Inc. | -3.230% | 5.517% | -11.561% | 118.571% | 34.211% | -72.920% | - |
Beximco Pharmaceuticals Ltd. GDR | - | 0.000% | -3.670% | 2.439% | -4.545% | -55.789% | -26.957% |
News
Want an Extra $500 in Annual Dividend Income? Invest $5,890 in These 3 High-Yield Dividend Stocks.
Investors eager to bulk up their passive income streams can do so without breaking the bank.
At recent prices, Hercules Capital (NYSE: HTGC), Altria Group (NYSE: MO), and AT&T (NYSE: T) offer an
1 Wall Street Analyst Thinks AT&T Stock Is Going to $20. Is It a Buy?
AT&T (NYSE: T) stock has struggled in recent years, but Barclays analyst Kannan Venkateshwar believes the company deserves a higher valuation, considering the recent subscriber gains for its
Better Dividend Stock: AT&T vs. Verizon
Income-seeking investors want to turn their heads toward the telecommunications industry. Two members of America's three-way telecom oligopoly offer huge dividend yields above 6% at the moment.
Veri